Predictors of Treatment Outcomes among Multidrug Resistant Tuberculosis Patients in Tanzania

Table 5

Adjusted OR after multivariate analysis for predictors of treatment outcome of completed treatment.

Characteristics	Completed treatment	Other treatment categories	aOR(95% CI)	p-value
	N (%)	N (%)
Baseline sputum smear
(i) Yes	32(15.2)	178(84.8)	2.09(0.66-6.61)	0.210
(ii) No	7(8.0)	81(92.0)
Baseline sputum culture
(i) Yes	22(14.3)	132(85.7)	1.25(0.47-3.29)	0.654
(ii) No	9(9.1)	90(90.9)
HIV status
(i) Yes	15(12.9)	101(87.1)	0.99(0.43-2.29)	0.977
(ii) No	28(13.0)	188(87.0)
Isoniazid
(i) Resistant	16(12.3)	114(87.7)	1.17(0.41-3.33)	0.765
(ii) susceptible	2(18.2)	9(81.2)
Rifampicin
(i) Resistant	26(12.9)	176(87.1)	1.56(0.55-4.43)	0.405
(ii) Susceptible	1(20.0)	4(80.0)
Streptomycin
(i) Resistant	9(11.3)	71(88.8)	0.31(0.08-1.26)	0.101
(ii) Susceptible	4(11.8)	30(88.2)
Ethambutol
(i) Resistant	7(9.6)	66(90.4)	2.49(0.68-9.03)	0.166
(ii) susceptible	6(16.2)	31(83.8)